Tensions surrounding the COVID-19 lockdowns are exceptionally high. Protestors across the US, Germany, France, and Spain—to name just a few—have rallied en masse to demand the lifting of legally-imposed quarantines. Now that economies have begun to reopen, social media has become its own battleground with many urging—even outright shaming—others to stay home and not go to work. So why hasn’t…
If you had you asked someone on New Year’s Day of 2020 what they envisioned the year ahead might look like, few would’ve imagined that the first few months would be spent canceling trips, events, and academic semesters. Families and college students hadn’t planned to spend their spring break in quarantine. Most businesses didn’t enter the year in fear of…
Over the past four decades, the Food and Drug Administration (FDA) has been approving new prescription drugs faster. That’s a great thing, since quicker approvals give terminally-ill patients faster access to potentially life-saving treatments. Of course, some critics aren’t happy, and it’s leading them to wonder if the FDA needs to slow “its drug approval roll.” But slowing down the approval process by bolstering…
This week, Right to Try became law of the land. It allows terminal patients, who do not qualify for clinical trials, to access experimental drugs that have not been fully approved by the FDA. This is a victory for patients who will no longer have to wait for government permission to access promising new treatment options. It will cut out…
Earlier this year, the City of Austin became the first city in Texas – and the South – to approve an extensive paid sick leave policy. This ordinance, which passed on a 9-2 vote by the Austin City Council, will require private businesses to provide paid sick leave to approximately 87,000 Austinites. The new law’s passage prompted applause by progressives…